Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inozyme Pharma Inc (INZY)

Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inozyme Pharma Inc 321 SUMMER STREET SUITE 400 BOSTON MA 02210 USA

www.inozyme.com Employees: 59 P: 857-330-4340

Description:

Inozyme Pharma Inc. is a biopharmaceutical company. It engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue and skeleton diseases. The company's product candidate consist INZ-701, which is in clinical stage. Inozyme Pharma Inc. is based in Boston, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 185,011
Enterprise Value, $K 195,191
Shares Outstanding, K 64,240
Annual Sales, $ 0 K
Annual Net Income, $ -71,170 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,570 K
EBIT, $ -99,680 K
EBITDA, $ -104,290 K
60-Month Beta 1.54
% of Insider Shareholders 11.19%
% of Institutional Shareholders 88.30%
Float, K 57,052
% Float 88.81%
Short Volume Ratio 0.27

Growth:

1-Year Return -13.80%
3-Year Return -64.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.39 on 11/05/24
Next Earnings Date N/A
Earnings Per Share ttm -1.56
EPS Growth vs. Prev Qtr 11.36%
EPS Growth vs. Prev Year -34.48%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

INZY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -88.42%
Return-on-Assets % -57.02%
Profit Margin % 0.00%
Debt/Equity 0.55
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.42
Book Value/Share 1.29
Interest Coverage -20.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar